PD1 – PDL1 Blockade Immunotherapy Applied as a Lung Cancer Treatment: Main Results, Proven Impact and Recent Knowledge Extensions
The ability of lung cancer to evade immunosurveillance is ensured by an "immune deficiency state" leading to a tolerance towards tumoral cell's antigens. Then, a theory that supports the anti-tumoral role of the immune system, made its strong proof, by individualization PDF